The European Medicines Agency's safety committee has concluded that a potentially dangerous eye condition is a very rare side ...

Novo Nordisk's popular weight-loss and diabetes drugs Wegovy and Ozempic may in very rare cases cause a serious eye condition ...

There are two types of ischemic optic neuropathy. Arteritic anterior ischemic optic neuropathy (A-AION) is caused by artery inflammation and is very dangerous. A-AION can be fatal, first causing ...

Treatment should be stopped if nonarteritic anterior ischemic optic neuropathy, which can cause vision loss, is diagnosed.

A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, ...

Anterior ischemic optic neuropathy (AION) occurs when there is not enough blood flow into the eye. This causes damage to the optic nerve, quickly leading to vision loss. There are two subtypes of ...

Nonarteritic, Anterior Ischemic Optic Neuropathy: A Case Study Louise Lee, EdD, MHA, CHSE, PA-C ; Alison Ip, PharmD Publish Date April 28, 2021 ...

NAION is one of two types of anterior ischemic optic neuropathy (AION). Both types of AION affect the optic disc, a 1-millimeter segment of the head of the optic nerve, causing visible swelling of ...

This page lists all known medications that could potentially lead to 'Anterior ischemic optic neuropathy' as a side effect. It's important to note that mild side effects are quite common with ...

5 Although permanent visual impairment persists in nearly all patients with nonarteritic anterior ION, the Ischemic Optic Neuropathy Decompression Trial (IONDT) showed that 43% of the patients ...

Given the evidence, the committee has recommended that the labels for Novo Nordisk’s Wegovy and Ozempic be updated to include ...

The European Medicines Agency's (EMA) safety committee (PRAC) has concluded its review of medicines containing semaglutide ...